Sunday, June 14, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 308 of 1,261
  1. CA 3174748

    UTILISATION DE MASITINIB POUR LE TRAITEMENT DE LA MALADIE A CORONAVIRUS 2019 (COVID-19)

    AB SCIENCE [FR] · Granted Oct 14, 2021 · Expires Oct 9, 2041

    granted
  2. US 11142750

    Optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome

    Precision BioSciences, Inc. · Granted Oct 12, 2021 · Expires Oct 7, 2041

    granted
  3. US 11141398

    Methods for decreasing injuries associated with intraoperative hypotension

    United States Government as represented by the Department of Veterans Affairs · Granted Oct 12, 2021 · Expires Oct 7, 2041

    granted
  4. US 11141434

    Programmed death 1 ligand 1 (PD-L1) binding proteins and methods of use thereof

    Iovance Biotherapeutics, Inc. · Granted Oct 12, 2021 · Expires Oct 7, 2041

    granted
  5. US 11141378

    Lipid formulations for nucleic acid delivery

    ARBUTUS BIOPHARMA CORPORATION · Granted Oct 12, 2021 · Expires Oct 7, 2041

    granted
  6. US 11142530

    Deep-sea fungus-derived anthraquinone compound and use thereof in preparing anti-allergic drugs

    China Ocean Mineral Resources R&D Association · Granted Oct 12, 2021 · Expires Oct 7, 2041

    granted
  7. US 11141452

    Bifunctional compounds for relief of pain comprising an opioid receptor agonist moiety and a NK1 receptor antagonist moiety and methods for treating pain

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Oct 12, 2021 · Expires Oct 7, 2041

    granted
  8. US 11142764

    Antisense antibacterial compounds and methods

    The Board of Regents of the University of Texas System · Granted Oct 12, 2021 · Expires Oct 7, 2041

    granted
  9. US 11142765

    Reagents for treatment of oculopharyngeal muscular dystrophy (OPMD) and use thereof

    Benitec IP Holdings Inc. · Granted Oct 12, 2021 · Expires Oct 7, 2041

    granted
  10. US 11142766

    Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof

    Alnylam Pharmaceuticals, Inc. · Granted Oct 12, 2021 · Expires Oct 7, 2041

    granted
  11. US 11142760

    Compositions and methods for treating hemoglobinopathies

    Beam Therapeutics Inc. · Granted Oct 12, 2021 · Expires Oct 7, 2041

    granted
  12. US 11142746

    High efficiency microfluidic purification of stem cells to improve transplants

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Oct 12, 2021 · Expires Oct 7, 2041

    granted
  13. US 11142578

    Anti-MET antibodies, bispecific antigen binding molecules that bind MET, and methods of use thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 12, 2021 · Expires Oct 7, 2041

    granted
  14. US 11142583

    BCMA-CAR-natural killer (NK) cells and methods related thereto

    Caribou Biosciences, Inc. · Granted Oct 12, 2021 · Expires Oct 7, 2041

    granted
  15. US 11142527

    Dihydropyrimidine compounds and uses thereof in medicine

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Oct 12, 2021 · Expires Oct 7, 2041

    granted
  16. US 11142505

    Compositions for APP-selective BACE inhibition and uses therefor

    The Regents of the University of California · Granted Oct 12, 2021 · Expires Oct 7, 2041

    granted
  17. US 11142533

    Macrocycles for use in treating disease

    TURNING POINT THERAPEUTICS, INC. · Granted Oct 12, 2021 · Expires Oct 7, 2041

    granted
  18. US 11141479

    Stable anti-OSMR antibody formulation

    Kiniksa Pharmaceuticals, GmbH · Granted Oct 12, 2021 · Expires Oct 7, 2041

    granted
  19. US 11141438

    Restimulation of cryopreserved tumor infiltrating lymphocytes

    Iovance Biotherapeutics, Inc. · Granted Oct 12, 2021 · Expires Oct 7, 2041

    granted
  20. US 11141496

    Use of berberine or derivative thereof in preparing myocardial perfusion imaging agent

    WEST CHINA HOSPITAL, SICHUAN UNIVERSITY · Granted Oct 12, 2021 · Expires Oct 7, 2041

    granted
  21. US 11141493

    Compositions and methods for treating CEP290-associated disease

    Editas Medicine, Inc. · Granted Oct 12, 2021 · Expires Oct 7, 2041

    granted
  22. US 11141465

    Method of making a water-soluble polymer-factor VIII moiety conjugate

    Nektar Therapeutics · Granted Oct 12, 2021 · Expires Oct 7, 2041

    granted
  23. US 11141418

    Methods and compositions for KRAS inhibitors

    The Board of Regents of the University of Texas System · Granted Oct 12, 2021 · Expires Oct 7, 2041

    granted
  24. US 11141404

    Formulations and methods for treating acute cannabinoid overdose

    Anebulo Pharmaceuticals, Inc. · Granted Oct 12, 2021 · Expires Oct 7, 2041

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.